Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

29 Jul 2014
Price Change (% chg)

¥53 (+1.22%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4523.T


Eisai Co., Ltd. is mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of drugs for pharmaceutical, over-the-counter and diagnostic uses. The Others segment manufactures and... (more)


Beta: 0.39
Market Cap (Mil.): ¥1,283,987.00
Shares Outstanding (Mil.): 296.57
Dividend: 70.00
Yield (%): 3.46


  4523.T Industry Sector
P/E (TTM): 37.50 35.65 36.07
EPS (TTM): 115.45 -- --
ROI: 4.37 18.91 18.18
ROE: 6.74 19.67 19.05
Search Stocks

REFILE-TABLE-Eisai -2013/14 group results

(Adds company forecast) May 13 - Eisai Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Mar 31, 2014 Mar 31, 2013 Mar 31, 2015 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST (Based on JPS)(Based on JPS)(Based on

12 May 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Reuters Investment Profile
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks